‘Halo-like’ device fits on head to quickly bust clots
A new device developed by a physician at the University of Arkansas for Medical Sciences and a researcher at the University of Arkansas at Little Rock could soon be available to treat stroke more effectively.
The ClotBust ER® fits on the head like a halo and delivers therapy to quickly bust clots that cause stroke.
It was developed by William Culp, M.D., professor of radiology, surgery and neurology and vice chairman of research at UAMS, and Doug Wilson, assistant director at the Graduate Institute of Technology at UALR.
Culp has spent many years studying therapy for stroke. One element of Culp’s work included using ultrasound in combination with the clot-busting drug tissue plasminogen activator (t-PA).
While looking into the treatment to dissolve clots in blood vessels, Culp realized one problem is getting the ultrasound to operate through the skull. Ultrasound can be delivered anywhere in a patient’s body unless the waves hit something hard like bone or something very soft, like air.
“We realized we had trouble delivering ultrasound to the vessels at the base of the brain,” Culp said. “The skull stopped the ultrasounds.”
He teamed with Wilson to brainstorm ideas about how to get the ultrasound waves to reach the clot in stroke patients.
“This is a great example of how faculty at both schools can partner to develop new technologies. The success of this research will foster ties between the two campuses,” Wilson said.
“It makes me extremely proud to have contributed to a product with potential to help many people,” he said.
Culp received an $8,000 grant from UAMS that provided him with the materials he needed to experiment. Wilson and Culp completed their first patent for “ultrasound for augmented clot lysis” in 2005. The patent was licensed in 2006 and has been in development by Cerevast Therapeutics.
The ClotBust ER® has 16 transducers scattered around the inside – designed to line up with the thin points in the skull: the temples and the foramen magnum in the base of the skull.
This allows the ultrasound waves to move through the brain without interruption. After the patient is administered an IV containing t-PA, the circular device is placed onto the patient’s head like a sports visor or halo.
“The idea is to deliver ultrasound wherever the clot is and where the IV t-PA is working,” Culp said. “It makes t-PA work better – improving the clot-busting drug by 40 or 50 percent. It’s like taking a cooking pot and stirring it. The ultrasound stirs the drug around, making it work better.”
The clot disappears more quickly. “If we resupply blood, we resupply oxygen. The brain recovers quicker. Quicker is, of course, better,” Culp said.
The Latest on: Stroke treatment
via Google News
The Latest on: Stroke treatment
- Woman gains vision after eye stroke with extensive three-year treatment at RAK hospitalon October 15, 2019 at 4:57 am
“While it is difficult to identify the reasons behind eye stroke, the condition is often linked to high blood pressure and diabetes which can increase the risk. Surprisingly, despite the fact that ...
- How Well Does Stroke Thrombectomy Work for Children?on October 14, 2019 at 2:22 pm
Sporns' study included all patients ages ≤18 years diagnosed with arterial ischemic stroke who underwent endovascular recanalization from 2000 through 2018 at participating centers. Most treatment was ...
- Mass General Hospital doctors create new liver disease treatment for people with HIVon October 12, 2019 at 1:37 pm
Many people with HIV have non-alcoholic fatty liver disease, for which there is no treatment and causes body composition abnormalities and could lead to an increased risk for stroke or heart attack.
- Using Simple Brain Scans Brainomix AI Software Can Generate Critical Information for the Treatment of Stroke Patientson October 11, 2019 at 5:05 pm
e-ASPECTS uses AI algorithms to automatically identify and quantify acute ischemic core within seconds of the scan acquisition. Ischemic core volume is increasingly being used by doctors to select ...
- The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reportson October 11, 2019 at 3:36 pm
The intricate mechanisms for stroke with and without cancer are different. This review summarizes the current clinical reports, pathophysiology, probable causes of co-occurrence, prognoses, and ...
- One image, one prediction: MRI may foretell cognitive decline after strokeon October 10, 2019 at 2:22 am
(Courtesy: Stroke 10.1161/STROKEAHA.119.025843/CC BY ... Others may develop dementia. While early treatment could help individuals at risk, identifying those who may go on to experience cognitive ...
- Ischaemic strokeon October 10, 2019 at 1:34 am
Accordingly, improving the system of care to reduce treatment delays is key to maximizing the benefits of reperfusion therapies. Intravenous thrombolysis reduces disability when administered within ...
- Stroke rates continue decline in the U.S.on October 9, 2019 at 1:24 pm
For example, after Ontario dedicated resources to better stroke treatment and prevention about a decade ago, both stroke and dementia rates decreased. "There's a strong indication that if we can ...
- Integrating Nonpharmacologic Treatment Options for Sickle Cell Diseaseon October 9, 2019 at 6:34 am
Minkoff, MD: There are nonpharmacologic treatments as well, where you can move into things like blood transfusion or even stem cell transplant. Can you talk about where those fit into your practice?
- Insera Announces First Two Stroke Patients Treated with its Cyclical Aspiration System, CLEARon October 8, 2019 at 5:02 pm
Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEAR TM stands for Cyclical, Luminal, Evacuation, Aspiration, and Retrieval. The ...
via Bing News